Exelixis Total Assets vs Total Current Liabilities Analysis
EXEL Stock | USD 21.74 0.19 0.87% |
Exelixis financial indicator trend analysis is much more than just examining Exelixis latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Exelixis is a good investment. Please check the relationship between Exelixis Total Assets and its Total Current Liabilities accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
Total Assets vs Total Current Liabilities
Total Assets vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Exelixis Total Assets account and Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Exelixis' Total Assets and Total Current Liabilities is 0.85. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Exelixis, assuming nothing else is changed. The correlation between historical values of Exelixis' Total Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Exelixis are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Assets i.e., Exelixis' Total Assets and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.85 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Assets
Total assets refers to the total amount of Exelixis assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Exelixis books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Exelixis balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Exelixis are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Exelixis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Exelixis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.At this time, Exelixis' Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 32.5 M this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.24.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.8B | 1.8B | Total Revenue | 1.4B | 1.6B | 1.8B | 1.9B |
Exelixis fundamental ratios Correlations
Click cells to compare fundamentals
Exelixis Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Exelixis fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.9B | 2.1B | 2.6B | 3.1B | 2.9B | 3.1B | |
Total Stockholder Equity | 1.7B | 1.9B | 2.2B | 2.5B | 2.3B | 2.4B | |
Retained Earnings | (559.4M) | (447.6M) | (216.5M) | (34.2M) | (173.4M) | (182.0M) | |
Common Stock Shares Outstanding | 315.0M | 318.0M | 322.4M | 324.6M | 321.5M | 178.5M | |
Liabilities And Stockholders Equity | 1.9B | 2.1B | 2.6B | 3.1B | 2.9B | 3.1B | |
Other Stockholder Equity | 2.2B | 2.3B | 2.4B | 2.5B | 2.4B | 1.4B | |
Short Long Term Debt Total | 50.7M | 49.1M | 51.3M | 190.2M | 189.9M | 156.7M | |
Other Current Liab | 21.7M | 176.2M | 313.3M | 267.5M | 329.4M | 345.9M | |
Total Current Liabilities | 142.7M | 204.7M | 337.6M | 324.4M | 394.3M | 414.0M | |
Property Plant And Equipment Net | 90.7M | 67.4M | 104.0M | 401.2M | 470.9M | 494.4M | |
Net Debt | (215.8M) | (270.1M) | (595.9M) | (311.0M) | (73.1M) | (69.4M) | |
Accounts Payable | 11.6M | 23.6M | 24.3M | 32.7M | 33.8M | 35.5M | |
Cash | 266.5M | 319.2M | 647.2M | 501.2M | 263.0M | 190.9M | |
Non Current Assets Total | 874.5M | 691.9M | 781.5M | 1.5B | 1.6B | 1.7B | |
Non Currrent Assets Other | 11.3M | 71.9M | 131.0M | 290.6M | 334.2M | 350.9M | |
Cash And Short Term Investments | 852.2M | 1.2B | 1.5B | 1.3B | 995.3M | 1.0B | |
Net Receivables | 119.1M | 160.9M | 282.7M | 214.8M | 237.4M | 249.3M | |
Short Term Investments | 585.7M | 887.3M | 819.9M | 807.3M | 732.3M | 768.9M | |
Non Current Liabilities Total | 57.0M | 53.6M | 68.0M | 258.7M | 284.2M | 213.1M | |
Other Current Assets | 27.0M | 57.0M | 57.5M | 62.2M | 67.9M | 71.3M | |
Total Liab | 199.7M | 258.2M | 405.6M | 583.1M | 678.4M | 370.3M | |
Total Current Assets | 1.0B | 1.4B | 1.8B | 1.6B | 1.3B | 1.4B | |
Accumulated Other Comprehensive Income | 3.1M | 4.5M | (758K) | (14.5M) | (3.8M) | (3.9M) | |
Short Term Debt | 2.7M | 3.0M | 8.7M | 17.7M | 25.7M | 50.4M | |
Common Stock | 305K | 312K | 319K | 324K | 303K | 287.9K | |
Other Liab | 8.9M | 4.5M | 16.8M | 68.5M | 78.8M | 83.4M | |
Other Assets | 185.3M | 187.1M | 197.5M | 286.9M | 329.9M | 346.4M | |
Common Stock Total Equity | 300K | 305K | 312K | 324K | 372.6K | 391.2K | |
Inventory | 12.9M | 21.0M | 27.5M | 33.3M | 17.3M | 9.5M | |
Property Plant And Equipment Gross | 90.7M | 67.4M | 144.9M | 462.1M | 551.2M | 578.8M | |
Property Plant Equipment | 48.9M | 67.4M | 149.2M | 110.6M | 127.2M | 133.6M | |
Current Deferred Revenue | 106.7M | 1.8M | 8.7M | 6.6M | 5.4M | 5.1M | |
Net Tangible Assets | 1.6B | 1.8B | 2.0B | 2.4B | 2.8B | 2.9B | |
Retained Earnings Total Equity | (880.4M) | (559.4M) | (447.6M) | (34.2M) | (39.4M) | (41.3M) | |
Capital Surpluse | 2.2B | 2.2B | 2.3B | 2.5B | 2.9B | 2.1B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Exelixis using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Exelixis Stock
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.65 | Revenue Per Share 5.914 | Quarterly Revenue Growth 0.04 | Return On Assets 0.043 | Return On Equity 0.0876 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.